In paediatric cardiac surgery, red blood cell (RBC) transfusions are given to treat haemorrhage or to increase oxygen delivery (therapeutic transfusion). Sometimes, RBCs are added to the prime solution to avoid a too low haematocrit on bypass (CPB-driven transfusion). Our study investigated whether the reason for RBC transfusion might affect severe postoperative morbidity or mortality.
INTRODUCTION
Children undergoing cardiac surgery are frequently exposed to red blood cell (RBC) transfusions [1] [2] [3] . Although several studies have shown an association between RBC transfusions and increased morbidity and mortality after cardiac surgery [4] [5] [6] , it is not known whether it is the transfusion itself or unmeasured confounders that are responsible for the impact of RBC transfusion on outcome [7] [8] [9] [10] .
Typically, RBCs are transfused to treat haemorrhage or to increase oxygen transport (therapeutic transfusion). However, in children undergoing cardiac surgery, RBCs may be administered to prime the cardiopulmonary bypass (CPB) circuit to avoid a low haematocrit during bypass. When RBCs are administered in the prime of the CPB, they are given in a priori stable patients and might therefore be associated with less complication compared with transfusions administered for haemorrhage or in haemodynamic unstable patients who need RBCs to increase low oxygen delivery.
We hypothesized that transfusions administered therapeutically would be associated with an increased morbidity and mortality compared with transfusions administered simply to avoid a low haematocrit during CPB. We therefore examined the relationship between the two indication groups for RBC transfusion and severe postoperative morbidity or mortality in children undergoing cardiac surgery on CPB.
METHODS

Study design
This retrospective cohort study (CEH no. 11/10) was approved by the Ethical Committee of the University Children's Hospital Queen Fabiola, Brussels, Belgium (Chairperson: J. Grosswasser) on 23 February 2010, which waived the need for informed consent. All consecutive children, aged 0-16 years, admitted for cardiac surgery with CPB from January 2006 to December 2009 were included. Jehovah's witnesses and moribund patients (ASA 5) were excluded. Demographic, anatomical, preoperative, intraoperative and postoperative data were retrieved from the patient's medical record after discharge. Exposure to RBC and other blood products and outcomes were followed during the entire hospital stay.
Clinical practice
Standard monitoring included five-lead electrocardiogram, pulse oximetry, non-invasive blood pressure, arterial and central venous pressures, urinary output and rectal and oesophageal temperatures. Intravenous anaesthesia based on midazolam, sufentanil and rocuronium was administered to all children, except those with univentricular physiology undergoing a cavopulmonary connection. In the latter, early extubation was warranted and anaesthesia was based on propofol, remifentanil and cisatracurium. Children were ventilated to maintain an arterial pCO 2 between 35 and 45 mmHg. All children received 30 mg kg −1 methylprednisolone after induction of anaesthesia. Before aortic cannulation, 4 mg kg −1 heparin was administered to achieve an activated clotting time >750 s.
The CPB circuit was primed with 6% hydroxyethyl starch (130/ 0.4) (Voluven®) or 4% albumin, 20% mannitol (1.5 mg kg −1 ), 20 mEq l −1 sodium bicarbonate and 50 mg l −1 heparin. In neonates, colloids were replaced with fresh frozen plasma. When preparing the CPB prime, the haematocrit of the child on bypass was calculated based on the volume of the prime and the estimated blood volume of the child. When the calculated haematocrit was to be lower than 20% after administration of cardioplegia, packed RBCs were added to the prime (CPB-driven transfusion). Antifibrinolytics were administered to nearly all patients: aprotinin was used from January 2006 to December 2007 (1 million IU m −2 at the induction of anaesthesia and in the CPB prime solution) and tranexamic acid was used from January 2008 to December 2009 (10 mg kg −1 was given after the induction of anaesthesia and in the CPB prime solution; a continuous infusion of 10 mg kg −1 h −1 until the end of surgery). A non-pulsatile flow (2.4-3.0 l m −2 min −1 ) was used in all children. The heart was protected with an antegrade, cold, crystalloid, cardioplegia (Ringer's lactate 20 ml kg −1 with KCl 30 mEq l −1 ). All patients were rewarmed to a temperature >35°C before separation from CPB. After weaning from CPB, modified ultrafiltration was used whenever possible. Protamine was titrated to antagonize heparin activity based on the heparinase-activated clotting time (Medtronic BV, Netherlands). Blood remaining in the CPB circuit was collected and re-transfused up to 6 h postoperatively, according to the child's needs. Packed RBCs were transfused in the operating room (OR) after separation from CPB in case of haemorrhage (to maintain a haematocrit >24% or haemoglobin level >8 g dl −1 ); or to increase oxygen delivery in case of persistent significant R-to L-shunt resulting in a low arterial oxygen saturation (SpO 2 < 90%), or in case of persistent lactic acidosis or low mixed venous or superior cava saturation after optimization of inotrope administration (therapeutic transfusions). The volume of blood transfused was adapted in each child according to the clinical situation. Platelet concentrates and fresh frozen plasma were transfused after CPB in the presence of abnormal clinical bleeding, using the algorithm developed by Despotis et al. [11] , based on platelet count, and standard coagulation tests. Intraoperative blood loss was obtained by weighting surgical sponges and measuring blood collected in volumetric containers by surgical aspiration. After surgery, children were admitted to the Paediatric Intensive Care Unit (PICU). Patients admitted after cavopulmonary connections or low-risk patients had their tracheas extubated in the OR. All other patients were weaned from the ventilator and extubated when they had an adequate cardiac output and oxygenation. Inotropes were maintained until resolution of clinical and biochemical signs of low cardiac output syndrome. In the PICU, transfusion decisions are based on established guidelines as defined in the TRIPICU study or the study of Cholette et al. [12, 13] . Packed RBCs were administered when the haemoglobin level dropped below 7 g dl −1 for bleeding or low oxygen transport. In cyanotic patients, RBCs were transfused when the haemoglobin level dropped below 9 g dl −1 or in cases of low oxygen saturation (taking into account the expected saturation) or in case of persistent signs of low cardiac output syndrome (based on clinical examination, diuresis, lactic acidosis, SaO 2 , superior vena cava saturation) after optimization of inotrope administration. Finally, patients were sent to the ward after they were weaned from the ventilator and from inotropic support and after removal of chest tubes.
Variables
Cardiac surgical procedures were categorized according to the Risk Adjusted Classification for Congenital Heart Surgery RACHS-1 [14] . Collected intraoperative variables included duration of CPB, aortic cross-clamp and deep hypothermic circulatory arrest. The Paediatric Index of Mortality and Paediatric Risk of Mortality scores were calculated [15, 16] . Redo surgery was defined as a previous cardiac surgery recorded in the patient's history.
All transfused patients received leukocyte-reduced RBCs. Based on the indication for RBC transfusion, two groups were defined: the therapeutic and the CPB-driven transfusion groups. As described above, patients in the therapeutic transfusion group were transfused in the OR after separation from CPB or in the PICU for haemorrhage or low oxygen transport. Patients in the CPB-driven transfusion group received only RBC a priori in the priming solution of the CPB circuit to prevent a too low haematocrit on bypass. Patients, who received RBCs both for priming the CPB circuit and for therapeutic purposes, were included in the therapeutic group.
The primary end-point was a composite outcome measure that included either hospital death and/or the presence of severe postoperative morbidity. Severe postoperative morbidity was defined as the presence of at least two of the following events: pulmonary failure, prolonged inotropic support or renal failure. Pulmonary failure was defined as the need for mechanical ventilation (from PICU admission to extubation) for more than 90 h, which included the 75th percentile of our study population, as proposed by Szekely et al. [4] . Prolonged inotropic support was defined as >5 µg kg −1 min −1 of either dopamine or dobutamine for more than 48 h postoperatively. Renal failure was defined as the worst estimated postoperative creatinine clearance (eCCr) value showing a ≥75% reduction compared with the preoperative baseline eCCr [17] . Secondary outcomes included: (i) infection, defined as the need for antibiotics other than the normal antistaphylococcal prophylaxis; these antibiotics were initiated by the attending intensive care physician, due to either a suspected or proven infection caused by any pathogen or a clinical syndrome associated with a high probability of infection, as defined by Goldstein et al. [18] (ii) neurological deficit, defined as a transient or permanent functional abnormality in a body area due to a reduction in brain function. Finally, the duration of mechanical ventilation, defined as the duration of invasive mechanical ventilation, and the PICU and hospital length of stay were compared between both groups. Both primary and secondary outcome measures were evaluated during primary hospitalization.
Statistical analysis
Continuous variables were presented as median and interquartile or mean and standard deviations, as appropriate. Normally distributed continuous variables were compared with Student's t-test, and non-normally ones were compared with the MannWhitney U-test. Categorical variables were presented as frequencies and percentages. The χ 2 test was used to test differences in proportions between the two groups.
Haemoglobin levels preoperatively, on postoperative day (POD) 1, 3 and 5 were compared between the two groups with a repeated-measure analysis of variance and the Bonferroni correction for multiple testing.
An univariate analysis was undertaken to define all possible predictors of severe postoperative morbidity or mortality. These variables were age, gender, preoperative weight, ASA, RACHS-1, previous cardiac surgery (Yes/No), preoperative oxygen saturation, cyanotic disease (Yes/No) cardiac status, preoperative haemoglobin, haematocrit; duration of intraoperative support (CPB, crossclamp, circulatory arrest), use and type of antifibrinolytic drug, minimal temperature on bypass, priming volume, intraoperative fluid balance, use of modified ultrafiltration, intraoperative blood loss, postoperative chest tube drainage (first 24 h and total), and calculated blood loss on the POD 3, as described by Hanart [19] , and indication for transfusion. Among these variables, those that had a P-value of < 0.10 were incorporated in the multivariable analysis to build the model that predict severe postoperative morbidity or mortality. The indication for transfusion was considered a dependent variable and it was dichotomized based on whether RBCs were used in the priming circuit or were given post-CPB for haemorrhage or low oxygen transport. The model obtained was then adjusted for all clinically relevant variables that may interfere with the variable 'indication for transfusion': age, gender, redo surgery, preoperative oxygen saturation, need for circulatory arrest, PRISM III and RACHS-1 score, total RBC transfusion and blood losses. Results of the multivariable analysis were presented as odds ratios (ORs) with 95% confidence intervals (95% CI). Finally, mortality over time was estimated with Kaplan-Meier survival curves. Survival curves were compared with the Log-rank test. A P-value of < 0.05 was considered statistically significant.
RESULTS
Patients
Between January 2006 and December 2009, 855 children underwent cardiac surgery with CPB and 844 were included in the database. Among the 568 transfused patients that were considered for this study, 210 (37.0%) received a therapeutic RBC transfusion and 358 (63.0%) received a CPB-driven RBC transfusion (Fig. 1) . Preoperative data, severity scores and intraoperative data are shown in Table 1 . In both groups, nearly all surgeries were elective but the difference was statistically significant. There was no difference in gender between both groups. Patients in the therapeutic transfusion indication group were younger, had lower oxygen saturation and also had a higher ASA score and a higher frequency of redo surgeries. They were also at higher risk of death according to RACHS-1, Paediatric Index of Mortality scores and Paediatric Risk of Mortality scores. Procedures performed in the therapeutic indication group were more complex. CPB priming volume, degree of haemodilution achieved at initiation of bypass and intraoperative fluid balance were comparable between the groups, as was the use of antifibrinolytics. Compared with the CPB-driven transfusion indication group, patients in the therapeutic group had longer duration of surgery, CPB and aortic cross-clamp. In addition, aortic cross-clamping and modified ultrafiltration were less frequent, circulatory arrest was more frequent, and minimal temperature during CPB was lower compared with the CPB-driven group.
Preoperative haemoglobin level was statistically different between the two groups; after surgery, haemoglobin levels were not statistically different between both groups (Fig. 2) . Data on haematological values, blood transfusions and blood loss are shown in Table 2 . The therapeutic group had significantly lower haematocrit values, platelet counts and fibrinogen levels throughout the study period. More patients in the therapeutic transfusion indication group received fresh frozen plasma and platelets than in the CPB-driven group. Overall, patients in the therapeutic group received significantly more blood products. Postoperative chest tube drainage and calculated blood loss at POD3 were significantly higher in the therapeutic group. Only intraoperative blood loss was similar between groups.
Outcomes
One hundred and one (48%) patients in the therapeutic group and 92 (26%) patients in the CPB-driven transfusion group developed severe postoperative morbidity or died (P < 0.001). The two groups showed statistically significant differences in severe postoperative morbidity and mortality. The number of patients with infections, or with a neurological deficit was statistically higher in the therapeutic group. Finally, the duration of mechanical ventilation, and the PICU and hospital length of stay, was significantly longer in the therapeutic group (Table 3) .
The multivariable logistic regression model found indication for transfusion (therapeutic vs CPB-driven), ASA score, calculated blood loss at POD3, intraoperative fluid balance and duration of CPB to be independent risk factors for severe postoperative morbidity or mortality. In this model, increasing preoperative weight was associated with a lower risk for severe postoperative morbidity or mortality (Table 4) . The model adjusted for the significant predictors of indication for transfusion (therapeutic vs CPB-driven), found that the indication for transfusion remained statistically significant for the primary outcome variable severe postoperative morbidity or mortality. In this model, we adjusted for age, gender, weight, redo surgery, RACHS-1 score, circulatory arrest, blood losses and RBC transfusion ( Table 5 ).
The survival rate was statistically higher in the CPB-driven compared with the therapeutic group (Kaplan-Meier P < 0.05) (Fig. 3 ).
DISCUSSION
Our study shows that the indication group for transfusion is an independent risk factor for severe postoperative morbidity or mortality in children who received a RBC transfusion during cardiac surgery in addition to other well-known risk factors, such as ASA score, duration of CPB, intraoperative fluid balance and bleeding (calculated blood loss at POD 3) [20] [21] [22] . The multivariable regression model shows that children receiving a therapeutic RBC transfusion have a 64% higher risk of developing severe postoperative morbidity or mortality. Even after adjustment for patient risk factors for morbidity or mortality (age, gender, redo surgery, preoperative oxygen saturation, need for circulatory arrest, PRISM III and RACHS-1 score, total blood losses and total RBC transfusion), the indication group for transfusion remains an independent risk factor for severe postoperative morbidity. Several studies have shown an association between RBC transfusion and increased morbidity [4] [5] [6] . The novel finding of our study is that it is the reason for transfusion rather than the transfusion itself that increases the perioperative risk. The reason for transfusion remaining an independent risk predictor of morbidity or mortality after adjusting for patient comorbidities and surgical factors can be explained by the fact that superimposing transfusion on increased surgical stress to the patient in and of itself confers increased risk to the patient [7] . Of course, it can also be related to other patient risk factors that were not adjusted for in this model (unmeasured confounding factors). This hypothesis has been raised by Karkouti et al. [8] in his recent article analysing the association of transfusion with postoperative mortality. However, one of these unmeasured confounding factors in the other studies might be the indication for transfusion. Our study shows that the indication for transfusion is a predictive factor for complications. The therapeutic transfusion indication group contains very ill patient who bleed and/or who have a low cardiac output syndrome and in whom oxygen delivery is compromised. In this group, RBC transfusion can be life-saving and morbidity could probably not be decreased by a restrictive transfusion strategy. In this particular group, it could be that the applied therapeutic approach is also a clinical relevant factor to be taken into account. In bleeding adult cardiac surgery patients, Weber et al. [23] demonstrated that a goal-oriented approach based on a predefined vertical algorithm regarding transfusions of blood products not only decreased the exposure to allogeneic blood product transfusions but also postoperative morbidity. In the CPB-driven transfusion indication group, RBCs were given prophylactically to maintain a predefined haematocrit on bypass. According to the results of our study, it might be that RBCs given in the priming do not negatively impact outcome. However, the influence of RBC-driven transfusion on outcome should be addressed in a further study by comparing patients having received RBCs during CPB and those who did not. Such analysis may help to better define the on-bypass transfusion threshold.
To our knowledge, this study is the first to evaluate the impact of the indication group for transfusion on outcome in paediatric cardiac surgery. Nevertheless, our study has some limitations. First, it is a retrospective, observational study; therefore, it is subject to uncontrolled confounding and potential misclassification biases. Some variables influencing severe postoperative morbidity and mortality may not have been collected for adjustment in the multivariate model [24] . Values represent the number (percentage), median (25th and 75th quartile) or mean ± standard deviation, as appropriate. b The third version of the PRISM score ranges from 0 to 76, with higher scores indicating a greater risk of death. Second, indication for transfusion is an independent predictor of severe postoperative morbidity or mortality even after adjustment for possible confounders of indication for transfusion. Yet, the association between the indication for transfusion and severe postoperative morbidity and mortality does not prove causality. Obviously, it would not be possible to design a randomized, controlled trial comparing CPB-driven and therapeutic transfusions but our results do suggest that RBC transfusion per se may be less significant than the indication for transfusion. Nevertheless, an important implication of this study is that when considering transfusions (yes/no) and the volume of blood product transfused as predictors of postoperative morbidity or mortality, the indication for transfusion has also to be taken into account.
Third, this study is based on the experience of a single centre. Therefore, local practice patterns might impede application of our results to other institutions. Our centre is a tertiary children's hospital that cares for all types of congenital heart diseases including high-risk patients undergoing complex surgery. The conclusions of our study may be difficult to generalize, because there is wide variability among centres regarding bypass and post-bypass transfusion triggers and management of anticoagulation.
Fourth, at our institution there is no formalized protocol for judging the readiness for extubation or ICU discharge. The latter was also dependent on local logistic factors. On the other hand, the same small group of anaesthesiologists, cardiac surgeons, cardiologists and paediatric intensivists treated all patients. Haemoglobin or haematocrit values used as transfusion triggers differed between the anaesthesiologists in the OR and the paediatricians in the PICU. This is mainly explained by the frequent haemodynamic instability and the important risk of bleeding immediately after bypass compared with a few hours later in the PICU. The presence of a formalized transfusion protocol in the OR and PICU provides consistency across physician decisions to transfuse. Fifth, it is difficult to compare different studies that have evaluated the impact of RBC transfusion on outcome in paediatric cardiac surgery because definitions of outcomes are different among different studies. Nevertheless, we attempted to improve comparability by choosing definitions that have been reported previously in other studies [12, 21] . Finally, controversy remains between the association of RBC storage and postoperative morbidity and mortality [25] . Unfortunately, data regarding the age of transfused RBCs were not available for this study.
In conclusion, this study is the first to evaluate the impact of the indication for transfusion on outcome in children undergoing cardiac surgery. Our results suggest that the indication for transfusion per se should be considered in further research on the effects of blood transfusions in paediatric cardiac surgery.
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